Canada· CA-DIN-02490722
LOKELMA
A sodium zirconium cyclosilicate product containing sodium zirconium cyclosilicate, registered in Canada by ASTRAZENECA CANADA INC. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Sodium zirconium cyclosilicate is registered in 14 of 19 countries.
Countries holding a registration under ATC V03AE10 (sodium zirconium cyclosilicate), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Sodium zirconium cyclosilicate · ATC V03AE10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sodium zirconium cyclosilicate costs, country by country.
Normalised to the WHO defined daily dose (7.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sodium zirconium cyclosilicate · price per daily dose (7.5 g)
USD · FX 28 Sept 2026
- FI Finland$1.86
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SODIUM ZIRCONIUM CYCLOSILICATE
- Manufacturer
- ASTRAZENECA CANADA INC
- Country
- Canada (CA)
- ATC code
- V03AE10
- ATC class
- Sodium zirconium cyclosilicate
- Defined daily dose
- 7.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for sodium zirconium cyclosilicate.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium zirconium cyclosilicate · interactions on record
20 records
- 20 moderate
Most severe, free to view
- FurosemideC03CA01moderate
- AtorvastatinC10AA05moderate
- KetoconazoleH02CA03moderate
- KetoconazoleJ02AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium zirconium cyclosilicate in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLOKELMAAstraZeneca AB, Södertälje
- FinlandLokelmaAbacus Medicine A/S
- NorwayLokelmaAstraZeneca AB (2)
- IcelandLokelmaAstraZeneca AB*
- NetherlandsLokelma 10 g, poeder voor orale suspensieZS Texas Ltd
- BelgiumLokelma 10 gAstraZeneca
- SwedenLokelma 10 g Pulver till oral suspensionAstraZeneca AB
- FranceLOKELMA 10 g, poudre pour suspension buvableASTRAZENECA AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lokelma
- Liechtenstein · Lokelma
- Norway · Lokelma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/890cbffb-ba7f-4c2d-b7e9-850e2ddda9f2 GET /v1/drugs/890cbffb-ba7f-4c2d-b7e9-850e2ddda9f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02490722",
"form": "POWDER FOR SUSPENSION",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "V03AE10",
"schedule": [
"Prescription"
],
"drug_code": "98078",
"strengths": [
"10 G"
],
"ahfs_class": null,
"substances": [
"SODIUM ZIRCONIUM CYCLOSILICATE"
],
"product_categorization": null
}See everything about sodium zirconium cyclosilicate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.